Boston Scientific Corp (BSX) 23.70 $BSX Global Vascular

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Boston Scientific Corp (BSX) 23.70 $BSX

Global Vascular Stents Market 2016-2020 With Abbott Laboratories, Boston Scientific, Cook Medical, Cordis, Medtronic & W.L. Gore & Associates Dominating - Research and Markets
BusinessWire - Tue Jul 12, 4:15AM CDT
Research and Markets has announced the addition of the "Global Vascular Stents Market 2016-2020" report to their offering.
BSX: 23.70 (-0.07), MDT: 89.15 (+0.64)

China Cardiac Rhythm Management Devices Market 2016-2020 - Key Vendors are BIOTRONIK, Boston Scientific, LivaNova & Medtronic - Research and Markets
BusinessWire - Mon Jul 11, 10:08AM CDT
Research and Markets has announced the addition of the "Cardiac Rhythm Management Devices Market in China 2016-2020" report to their offering.
BSX: 23.70 (-0.07), MDT: 89.15 (+0.64)

Henry Schein Rides High on Strategic Buyouts, Price Hurts
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 8:58AM CDT
Henry Schein's (HSIC) latest acquisition development includes the completion of its takeover of 50% interest in J Morita's subsidiary, One Piece Corp.
BSX: 23.70 (-0.07), ICUI: 115.00 (-0.74), HSIC: 181.32 (-0.46), NUVA: 61.12 (-0.45)

Global Cardiac Resynchronization Therapy Defibrillator Market Growth of 8.36% CAGR by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Key Vendors: Boston Scientific, Medtronic, BIOTRONIK - Research and Markets
BusinessWire - Wed Jul 06, 10:13AM CDT
Research and Markets has announced the addition of the "Global Cardiac Resynchronization Therapy Defibrillator Market 2016-2020" report to their offering.
BSX: 23.70 (-0.07), MDT: 89.15 (+0.64)

Cooper Companies Strong on Portfolio Expansion Plans
Zacks Equity Research - Zacks Investment Research - Wed Jul 06, 8:38AM CDT
The Cooper Companies Inc. (COO) is firing on all cylinders, buoyed by its expanding product portfolio and consistent earnings results.
BSX: 23.70 (-0.07), JNJ: 122.79 (-0.14), BEAT: 17.65 (+0.15), COO: 179.95 (-2.15)

Zimmer Biomet Poised on LDR Inclusion, Product Launches
Zacks Equity Research - Zacks Investment Research - Wed Jul 06, 8:12AM CDT
On Jul 4, 2016, we issued an updated research report on Zimmer Biomet Holdings, Inc. (ZBH).
BSX: 23.70 (-0.07), ICUI: 115.00 (-0.74), ZBH: 125.84 (+0.76), NUVA: 61.10 (-0.47)

Shares of BSX Up 29.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Jul 05, 1:09PM CDT
SmarTrend identified an Uptrend for Boston Scientific (NYSE:BSX) on March 14th, 2016 at $18.01. In approximately 4 months, Boston Scientific has returned 29.58% as of today's recent price of $23.33.
BSX: 23.70 (-0.07)


FDA approves first dissolving stent for US patients
By MATTHEW PERRONE - AP - Tue Jul 05, 4:30PM CDT
WASHINGTON (AP) — A medical implant that slowly dissolves into the body could be the answer to long-standing safety concerns with devices used to treat clogged arteries.
BSX: 23.70 (-0.07), ABT: 42.36 (+0.24), MDT: 89.15 (+0.64)

Abaxis: Growth on Test Menu Expansion; Competition Rife
Zacks Equity Research - Zacks Investment Research - Tue Jul 05, 10:38AM CDT
Abaxis (ABAX) has been working on expanding its portfolio of rapid test menu over the recent past.
BSX: 23.70 (-0.07), ICUI: 115.00 (-0.74), ABAX: 52.35 (+0.35), NUVA: 61.10 (-0.47)

NuVasive (NUVA) at 52-Week High on Strategic Initiatives
Zacks Equity Research - Zacks Investment Research - Tue Jul 05, 8:03AM CDT
Currently, NuVasive (NUVA) expects its international business to grow by 38% in 2016, at CER.
BSX: 23.70 (-0.07), ICUI: 115.00 (-0.74), GWPH: 96.81 (+0.46), NUVA: 61.10 (-0.47)

Akers Biosciences Chlamydia Rapid Test Results Positive
Zacks Equity Research - Zacks Investment Research - Fri Jul 01, 8:33AM CDT
Shares of Akers Biosciences Inc. (AKER) surged 15.8% to close at $3.22 following the completion of a clinical trial on the company's Chlamydia rapid test.
BSX: 23.70 (-0.07), ICUI: 115.00 (-0.74), CAH: 81.89 (+0.83), AKER: 2.90 (+0.10)

Myriad Genetics: Study Data Drives Growth, Competition Rife
Zacks Equity Research - Zacks Investment Research - Fri Jul 01, 7:51AM CDT
Most recent study data from the Nova trial shows Myriad's (MYGN) myChoice HRD test's effectiveness in detecting an increased number of ovarian cancer patients
BSX: 23.70 (-0.07), ICUI: 115.00 (-0.74), MYGN: 32.21 (+0.15), LMAT: 13.91 (+0.27)

GNC Holdings' Overseas Prospects Robust Amid Market Woes
Zacks Equity Research - Zacks Investment Research - Thu Jun 30, 4:35PM CDT
On Jun 30, 2016, we issued an updated research report on Pittsburgh, PA-based GNC Holdings, Inc. (GNC).
BSX: 23.70 (-0.07), ICUI: 115.00 (-0.74), GNC: 26.17 (+0.42), STJ: 80.87 (+0.20)

Medtronic (MDT) Focuses on Cardiac Management Portfolio
Zacks Equity Research - Zacks Investment Research - Thu Jun 30, 9:00AM CDT
Following the release, shares of Medtronic gained 1.56% to reach $85.45 at the end of yesterday's trading session.
BSX: 23.70 (-0.07), ICUI: 115.00 (-0.74), MDT: 89.15 (+0.64), STJ: 80.87 (+0.20)

Research Report Initiated on Select Medical Appliances & Equipment Equities
ACCESSWIRE - Thu Jun 30, 8:15AM CDT
LONDON, UK / ACCESSWIRE / June 30, 2016 / Active Wall St announces the list of stocks for today's research coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Medical Appliances & Equipment industry. Companies recently under review include Boston Scientific, Abbott Laboratories, Medtronic, and Hologic. See our complete report on Boston Scientific at:
BSX: 23.70 (-0.07), ABT: 42.36 (+0.24), MDT: 89.15 (+0.64), HOLX: 35.73 (+0.12)

CR Bard (BCR) at 52-Week High on Strong Product Pipeline
Zacks Equity Research - Zacks Investment Research - Thu Jun 30, 7:27AM CDT
Shares of CR Bard (BCR) rallied to a new 52-week high of $232.77 on Jun 29.
HYH: 34.65 (+0.39), BSX: 23.70 (-0.07), BCR: 236.65 (-0.52), CNMD: 49.82 (+0.49)

Baxter International: Health Canada Okays AMIA APD System
Zacks Equity Research - Zacks Investment Research - Thu Jun 30, 7:27AM CDT
Baxter International Inc. (BAX) is forging ahead with its expansion plans in Canada with the launch of AMIA Automated Peritoneal Dialysis (APD) System.
BSX: 23.70 (-0.07), ICUI: 115.00 (-0.74), BAX: 46.88 (+0.39), NUVA: 61.10 (-0.47)

Boston Scientific Set to Possibly Pullback After Yesterday's Rally of 3.04%
Comtex SmarTrend(R) - Wed Jun 29, 2:50PM CDT
Boston Scientific (NYSE:BSX) traded in a range yesterday that spanned from a low of $22.55 to a high of $23.03. Yesterday, the shares gained 3.0%, which took the trading range above the 3-day high of $22.95 on volume of 4.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BSX: 23.70 (-0.07)

Look for Shares of Boston Scientific to Potentially Pullback after Yesterday's 3.04% Rise
Comtex SmarTrend(R) - Wed Jun 29, 2:49PM CDT
Boston Scientific (NYSE:BSX) traded in a range yesterday that spanned from a low of $22.55 to a high of $23.03. Yesterday, the shares gained 3.0%, which took the trading range above the 3-day high of $22.95 on volume of 4.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BSX: 23.70 (-0.07)

Illumina, MolecularMD to Co-Develop Oncology Diagnostics
Zacks Equity Research - Zacks Investment Research - Wed Jun 29, 8:07AM CDT
The collaboration will combine Illumina's (ILMN) expertise in NGS technology with MolecularMD's experience in developing molecular testing for new oncology drugs
BSX: 23.70 (-0.07), ICUI: 115.00 (-0.74), LMAT: 13.91 (+0.27), ILMN: 146.28 (+6.64)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 362

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 39

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 481

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 298

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 527

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 419

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 583

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 90

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 407

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading

Top 5 Most Recently Viewed Articles

Sentry Insurance Company Announces Strategic Acquisition Plans

Updated Category News Views 205

Insights into Sentry Insurance Company's Acquisition Strategy OLDWICK, N.J.--AM Best has announced that the Credit Ratings of Sentry Insurance Company, along with its subsidiaries—collectively known as Sentry—will stay stable after the recent news of their acquisition of The General from American Family Insurance Group. This deal includes Permanent General Assurance...

Continue Reading
Growth Outlook for the Automotive Horn System Market

Updated Category News Views 165

Overview of the Automotive Horn System Market Wilmington, Delaware - A recent market analysis reveals a significant shift in the automotive horn system industry. The report estimates that the market, currently valued at $0.7 billion, is projected to grow to $1.8 billion by the end of the forecast period in 2033, achieving an impressive compound annual growth rate (CAGR)...

Continue Reading
Payoneer Completes Warrant Purchase Offer and Amendments

Updated Category News Views 105

Payoneer Completes Warrant Purchase Offer and Consent Solicitation Payoneer Global Inc. (NASDAQ: PAYO), a financial technology company serving businesses worldwide, has completed its cash offer to buy outstanding Warrants at $0.78 each. The move is designed to simplify Payoneer’s capital structure and give warrant holders a clear cash alternative, while keeping the...

Continue Reading
The Aesthetic Medicine Market's Future: Key Trends to Watch

Updated Category News Views 251

Sales Expectations for the Aesthetic Medicine Market The global aesthetic medicine market was estimated at US$ 83.12 billion recently, with projections indicating a remarkable potential to rise to US$ 233.67 billion by the year 2033. This growth is anticipated at a compound annual growth rate (CAGR) of 12.17% from 2025 through to 2033. Impact of Technological Innovations...

Continue Reading
Bauducco's Florida Expansion Boosts U.S. Manufacturing

Updated Category News Views 74

New Facility Marks a Strategic Shift for Bauducco Imagine three generations crafting baked goods, and then picture this: Bauducco, the Brazilian icon for snacks like wafer cookies and Panettone, boldly stepping onto the U.S. manufacturing stage. They have just swung wide the doors of their largest stateside factory, right in Zephyrhills, Florida. They're not here to...

Continue Reading